Welcome to LookChem.com Sign In|Join Free

CAS

  • or

181427-78-1

181427-78-1

Post Buying Request

181427-78-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

181427-78-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 181427-78-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,1,4,2 and 7 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 181427-78:
(8*1)+(7*8)+(6*1)+(5*4)+(4*2)+(3*7)+(2*7)+(1*8)=141
141 % 10 = 1
So 181427-78-1 is a valid CAS Registry Number.
InChI:InChI=1/C13H12O6/c1-6(12(15)16)10-4-7-3-8(18-2)5-9(14)11(7)13(17)19-10/h3-6,14H,1-2H3,(H,15,16)

181427-78-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(8-hydroxy-6-methoxy-1-oxoisochromen-3-yl)propanoic acid

1.2 Other means of identification

Product number -
Other names NM 3

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:181427-78-1 SDS

181427-78-1Downstream Products

181427-78-1Relevant articles and documents

Tumor chemopotentiation using isocoumarin derivatives

-

, (2008/06/13)

A method for enhancing the efficacy of chemotherapy in the treatment of cancer in animals, particularly humans, is provided wherein isocoumarin derivatives that exhibit unique chemopotentiation properties are employed in a combination treatment with chemotherapy.

Tumor chemopotentiation using isocoumarin derivatives

-

, (2008/06/13)

A method for enhancing the efficacy of chemotherapy in the treatment of cancer in animals, particularly humans, is provided wherein isocoumarin derivatives that exhibit unique chemopotentiation properties are employed in a combination treatment with chemotherapy.

Isocoumarin derivatives and use thereof in drugs

-

, (2008/06/13)

PCT No. PCT/JP96/01657 Sec. 371 Date Dec. 17, 1998 Sec. 102(e) Date Dec. 17, 1998 PCT Filed Jun. 17, 1996 PCT Pub. No. WO97/48693 PCT Pub. Date Dec. 24, 1997Compounds of the formula (I) wherein R is a hydrogen atom or a C1-6 alkyl group and n is an integer of 0 or 1, and pharmaceutical preparations thereof are provided. These pharmaceutical preparations are useful for the prevention or treatment of diseases associated with an abnormality in immunological regulatory function or vascularization.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 181427-78-1